Table 3.
Adverse Events (N =20)
| Grade | |||||
|---|---|---|---|---|---|
| Adverse Event | 0 | 1 | 2 | 3 | 4 |
| Leukopenia | 2 | 0 | 7 | 10 | 1 |
| Thrombocytopenia | 13 | 4 | 0 | 3 | 0 |
| Neutropenia | 2 | 0 | 2 | 11 | 5 |
| Anemia | 3 | 10 | 6 | 1 | 0 |
| Other hematologic | 18 | 0 | 2 | 0 | 0 |
| Coagulation | 19 | 1 | 0 | 0 | 0 |
| Hemorrhage | 18 | 2 | 0 | 0 | 0 |
| Nausea | 3 | 11 | 6 | 0 | 0 |
| Vomitting | 7 | 10 | 3 | 0 | 0 |
| Bilirubin | 19 | 1 | 0 | 0 | 0 |
| ALT | 9 | 4 | 5 | 2 | 0 |
| Alkaline phosphatase | 19 | 1 | 0 | 0 | 0 |
| Dermatologic | 14 | 4 | 2 | 0 | 0 |
| Infection | 17 | 0 | 2 | 1 | 0 |
| Pulmonary | 15 | 4 | 1 | 0 | 0 |
| Metabolic | 8 | 5 | 4 | 3 | 0 |
| Lymphatics | 16 | 4 | 0 | 0 | 0 |
| Pain | 8 | 10 | 2 | 0 | 0 |
| Constitutional | 17 | 3 | 0 | 0 | 0 |
| Fatigue | 5 | 8 | 7 | 0 | 0 |
| Musculoskeletal | 15 | 4 | 1 | 0 | 0 |
| Neurotoxicity | 16 | 4 | 0 | 0 | 0 |
| Peripheral neuropathy | 18 | 2 | 0 | 0 | 0 |
| Renal | 19 | 1 | 0 | 0 | 0 |
| Ocular | 16 | 3 | 1 | 0 | 0 |
| Vascular | 19 | 0 | 0 | 1 | 0 |
| Flu-like syndrome | 19 | 0 | 1 | 0 | 0 |